Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Digital Adherence Monitoring of Inhalative Therapy in Real- Life Conditions

NCT04656223 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT04656223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04656223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Digital Adherence Monitoring of Inhalative Therapy in Real- Life Conditions
Lead sponsor
Novartis Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
December 17, 2020
Completion date
January 20, 2023
Enrollment
434 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

asthma